Circadian Variation of Stent Thrombosis and the Effect of More Robust Platelet Inhibition: A Post Hoc Analysis of the TRITON-TIMI 38 Trial
Conclusions:
In TRITON-TIMI 38 trial, the timing of ST exhibited a significant diurnal variation similar to that seen with onset of other acute coronary syndromes. ST occurred less frequently among patients randomized to prasugrel compared to clopidogrel with the greatest absolute reduction (6.2 per 1000 patients) in events earlier in the day when platelet activity is known to be highest.
Source: Journal of Cardiovascular Pharmacology and Therapeutics - Category: Cardiology Authors: Mogabgab, O., Wiviott, S. D., Cannon, C. P., Sloan, S., Sabatine, M. S., Antman, E. M., Braunwald, E., Giugliano, R. P. Tags: Clinical Studies Source Type: research
More News: Academia | Angioplasty | Cardiology | Cardiovascular | Clopidogrel | Coronary Angioplasty | Drugs & Pharmacology | Heart | Heart Attack | Percutaneous Coronary Intervention | Plavix | Study | Thrombosis